Multicentric Prospective Cohort Study of Patients with Chronic Alcoholic and/or Metabolic Liver Disease

{
"level_sex_clusion_I": [
{
"value": "Male",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008297"
}
},
{
"value": "Female",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D005260"
}
}
],
"level_age_clusion_I": [
{
"value": "Young Adult (19 to 24 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D055815"
}
},
{
"value": "Adult (25 to 44 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000328"
}
},
{
"value": "Middle Aged (45 to 64 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008875"
}
},
{
"value": "Aged (65 to 79 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000368"
}
},
{
"value": "Aged, 80 and over (80 years and more)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000369"
}
}
],
"level_type_clusion_I": [
"Patients population"
],
"level_type_clusion_other": "",
"clusion_I": "over 18 years of age; - liver disease whose severity was determined by hepatic puncture biopsy (HPB) or non-invasive markers of fibrosis or FibroScan: - HPB with bridging fibrosis or cirrhosis (regardless of the date and method of liver sample); - Fibrotest greater than 0.58 and at least 6 months old - Measurement of liver stiffness by FibroScan greater than 7.9 kPa (with IQR\/LSM less than 0.30) older than 6 months; - no previous decompensated cirrhosis (gastrointestinal bleeding or clinical ascites) or CHC (treated or untreated); - existence of criteria demonstrating a history or continuance of chronic alcohol use, defined by consumption of 30 g per day for men and 20 g per day for women for at least 10 years (more than 21 drinks per week for men and 14 drinks per week for women); - presence of 3 metabolic syndrome criteria: increased waist circumference (greater than 102 cm for men, greater than 88 cm for women), diabetes or elevated fasting blood glucose (greater than or equal to 6.1 mmol \/l), treated or untreated arterial hypertension (greater than or equal to 130\/85 mmHg), decreased HDL cholesterol (less than 1.04 mmol\/l for men, less than 1.28 mmol\/l for women) elevated triglycerides (greater than 1.6 mmol \/l - Lancet 2005); - individuals covered by social security insurance; - who have received clear and honest information regarding the study and given written consent.",
"clusion_E": ""
}